MoneyWorks4Me

A decent increase of about 62.68% in the turnover to Rs. 1014.92 millions was observed for the quarter ended September 2024. The turnover stood at Rs. 623.87 millions during the similar quarter previous year.Net profit surges 76.47% to Rs. 109.50  millions  from Rs. 62.05 millions in the quarter ended September 2024.The company reported a good operating profit of 161.13 millions compared to 100.95 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1014.92 623.87 62.68 1883.23 1217.51 54.68 2583.60 2246.44 15.01
Other Income 41.84 40.04 4.50 54.97 58.81 -6.53 131.01 146.10 -10.33
PBIDT 161.13 100.95 59.61 278.97 181.31 53.86 409.55 342.22 19.67
Interest 1.62 10.76 -84.94 5.48 21.98 -75.07 44.49 31.30 42.14
PBDT 159.49 90.19 76.84 273.47 159.33 71.64 364.82 311.05 17.29
Depreciation 13.00 8.79 47.90 26.00 19.79 31.38 47.22 45.39 4.03
PBT 146.49 81.40 79.96 247.47 139.54 77.35 317.60 265.66 19.55
TAX 36.99 19.35 91.16 61.68 35.00 76.23 81.36 64.95 25.27
Deferred Tax 2.13 4.51 -52.77 2.44 4.13 -40.92 5.54 -1.53 -462.09
PAT 109.50 62.05 76.47 185.79 104.54 77.72 236.24 200.71 17.70
Equity 940.00 940.00 0.00 940.00 940.00 0.00 940.00 940.00 0.00
PBIDTM(%) 15.88 16.18 -1.89 14.81 14.89 -0.53 15.85 15.23 4.06

Syncom Formulations Share Price

13.44 0.25 (1.90%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: